The impact of patent expiry can be an unsettling prospect. It can change the balance of your portfolio, open up new competition in the form of generics, and shift your market strategy around the world.
Patent intelligence solutions from IQVIA deliver the data and analytics you need. Backed by data on thousands of patent families for both small molecule and biologics, and include in-depth analysis of patents, data exclusivity, and extensions, our team is ready to help you
Go beyond the numbers to analytics-driven insights using artificial intelligence, machine learning and healthcare expertise.
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.